107 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
, including those relating to patient privacy; determinations by regulatory and administrative governmental authorities which may delay or restrict
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy
8-K
EX-99.1
u6h rerp5m
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
pc5yrlm
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
EX-99.1
xvyvma9n0ri5 pv
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
2x1h0q
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
8-K
EX-99.1
4dww9naitu4
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
8-K
EX-99.1
ugk 7vz4sl7
3 Aug 22
Regeneron Reports Second Quarter 2022 Financial and Operating Results
7:08am
SC TO-T/A
EX-99
zo2743ko04 xym7
31 May 22
Third party tender offer statement (amended)
8:38am